請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10647完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 許秉寧(Ping-Ning Hsu) | |
| dc.contributor.author | Li-Pu Huang | en |
| dc.contributor.author | 黃立普 | zh_TW |
| dc.date.accessioned | 2021-05-20T21:46:36Z | - |
| dc.date.available | 2012-09-09 | |
| dc.date.available | 2021-05-20T21:46:36Z | - |
| dc.date.copyright | 2010-09-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-08-05 | |
| dc.identifier.citation | Ahmad, S., Banville, D., Zhao, Z., Fischer, E.H., and Shen, S.H. (1993). A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. Proc Natl Acad Sci U S A 90, 2197-2201.
Amieva, M.R., Vogelmann, R., Covacci, A., Tompkins, L.S., Nelson, W.J., and Falkow, S. (2003). Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300, 1430-1434. Ashton-Key, M., Biddolph, S.C., Stein, H., Gatter, K.C., and Mason, D.Y. (1995). Heterogeneity of bcl-2 expression in MALT lymphoma. Histopathology 26, 75-78. Blaser, M.J. (1987). Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 93, 371-383. Blaser, M.J. (2002). Polymorphic bacteria persisting in polymorphic hosts: assessing Helicobacter pylori-related risks for gastric cancer. J Natl Cancer Inst 94, 1662-1663. Cattoretti, G., Chang, C.C., Cechova, K., Zhang, J., Ye, B.H., Falini, B., Louie, D.C., Offit, K., Chaganti, R.S., and Dalla-Favera, R. (1995). BCL-6 protein is expressed in germinal-center B cells. Blood 86, 45-53. Chang, Y.J., Wu, M.S., Lin, J.T., Pestell, R.G., Blaser, M.J., and Chen, C.C. (2006). Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle. Cell Microbiol 8, 1740-1752. Choi, I.J., Kim, J.S., Kim, J.M., Jung, H.C., and Song, I.S. (2003). Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun 71, 830-837. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., Figura, N., et al. (1993). Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 90, 5791-5795. Cover, T.L., Dooley, C.P., and Blaser, M.J. (1990). Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 58, 603-610. Crabtree, J.E., Taylor, J.D., Wyatt, J.I., Heatley, R.V., Shallcross, T.M., Tompkins, D.S., and Rathbone, B.J. (1991). Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 338, 332-335. Crowe, S.E. (2005). Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 21, 32-38. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D., and Staudt, L.M. (1997). Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276, 589-592. Du, M.Q., and Isaccson, P.G. (2002). Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 3, 97-104. Feng, G.S., Hui, C.C., and Pawson, T. (1993). SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 259, 1607-1611. Frearson, J.A., and Alexander, D.R. (1998). The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. J Exp Med 187, 1417-1426. Freeman, R.M., Jr., Plutzky, J., and Neel, B.G. (1992). Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci U S A 89, 11239-11243. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70. Higashi, H., Tsutsumi, R., Fujita, A., Yamazaki, S., Asaka, M., Azuma, T., and Hatakeyama, M. (2002a). Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 99, 14428-14433. Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., and Hatakeyama, M. (2002b). SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683-686. Higashi, H., Yokoyama, K., Fujii, Y., Ren, S., Yuasa, H., Saadat, I., Murata-Kamiya, N., Azuma, T., and Hatakeyama, M. (2005). EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 280, 23130-23137. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., and Korsmeyer, S.J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M.J., and Shoelson, S.E. (1998). Crystal structure of the tyrosine phosphatase SHP-2. Cell 92, 441-450. Holgado-Madruga, M., Emlet, D.R., Moscatello, D.K., Godwin, A.K., and Wong, A.J. (1996). A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379, 560-564. Inagaki, K., Noguchi, T., Matozaki, T., Horikawa, T., Fukunaga, K., Tsuda, M., Ichihashi, M., and Kasuga, M. (2000). Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion and cell migration revealed by overexpression of a dominant negative mutant. Oncogene 19, 75-84. Isaacson, P.G., Wotherspoon, A.C., Diss, T.C., and Pan, L.X. (1991). Bcl-2 expression in lymphomas. Lancet 337, 175-176. Kazlauskas, A., Feng, G.S., Pawson, T., and Valius, M. (1993). The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc Natl Acad Sci U S A 90, 6939-6943. Kusters, J.G., van Vliet, A.H., and Kuipers, E.J. (2006). Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19, 449-490. Lin, W.C., Tsai, H.F., Kuo, S.H., Wu, M.S., Lin, C.W., Hsu, P.I., Cheng, A.L., and Hsu, P.N. (2010). Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res 70, 5740-5748. Manes, S., Mira, E., Gomez-Mouton, C., Zhao, Z.J., Lacalle, R.A., and Martinez, A.C. (1999). Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol Cell Biol 19, 3125-3135. Maroun, C.R., Naujokas, M.A., Holgado-Madruga, M., Wong, A.J., and Park, M. (2000). The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 20, 8513-8525. Marshall, B.J., and Warren, J.R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315. Mimuro, H., Suzuki, T., Tanaka, J., Asahi, M., Haas, R., and Sasakawa, C. (2002). Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell 10, 745-755. Moriyama, M., Yamochi, T., Semba, K., Akiyama, T., and Mori, S. (1997). BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo. Oncogene 14, 2465-2474. Naito, M., Yamazaki, T., Tsutsumi, R., Higashi, H., Onoe, K., Yamazaki, S., Azuma, T., and Hatakeyama, M. (2006). Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130, 1181-1190. Nardone, G., Rocco, A., Vaira, D., Staibano, S., Budillon, A., Tatangelo, F., Sciulli, M.G., Perna, F., Salvatore, G., Di Benedetto, M., et al. (2004). Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. J Pathol 202, 305-312. Nunez, G., Seto, M., Seremetis, S., Ferrero, D., Grignani, F., Korsmeyer, S.J., and Dalla-Favera, R. (1989). Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. Proc Natl Acad Sci U S A 86, 4589-4593. Odenbreit, S., Puls, J., Sedlmaier, B., Gerland, E., Fischer, W., and Haas, R. (2000). Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497-1500. Ohnishi, N., Yuasa, H., Tanaka, S., Sawa, H., Miura, M., Matsui, A., Higashi, H., Musashi, M., Iwabuchi, K., Suzuki, M., et al. (2008). Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A 105, 1003-1008. Pluskey, S., Wandless, T.J., Walsh, C.T., and Shoelson, S.E. (1995). Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem 270, 2897-2900. Qu, C.K., Yu, W.M., Azzarelli, B., and Feng, G.S. (1999). Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals. Proc Natl Acad Sci U S A 96, 8528-8533. Saadat, I., Higashi, H., Obuse, C., Umeda, M., Murata-Kamiya, N., Saito, Y., Lu, H., Ohnishi, N., Azuma, T., Suzuki, A., et al. (2007). Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447, 330-333. Schubbert, S., Lieuw, K., Rowe, S.L., Lee, C.M., Li, X., Loh, M.L., Clapp, D.W., and Shannon, K.M. (2005). Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood 106, 311-317. Selbach, M., Moese, S., Hauck, C.R., Meyer, T.F., and Backert, S. (2002). Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 277, 6775-6778. Shaffer, A.L., Yu, X., He, Y., Boldrick, J., Chan, E.P., and Staudt, L.M. (2000). BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13, 199-212. Shen, Y., Iqbal, J., Huang, J.Z., Zhou, G., and Chan, W.C. (2004). BCL2 protein expression parallels its mRNA level in normal and malignant B cells. Blood 104, 2936-2939. Sheu, B.S., Yang, H.B., Wu, J.J., Huang, A.H., Lin, X.Z., and Su, I.J. (1999). Development of Helicobacter pylori infection model in BALB/c mice with domestic cagA-positive and -negative strains in Taiwan. Dig Dis Sci 44, 868-875. Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., and Tsujimoto, Y. (1995). Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374, 811-813. Stein, M., Bagnoli, F., Halenbeck, R., Rappuoli, R., Fantl, W.J., and Covacci, A. (2002). c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 43, 971-980. Tammer, I., Brandt, S., Hartig, R., Konig, W., and Backert, S. (2007). Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 132, 1309-1319. Tang, T.T., Dowbenko, D., Jackson, A., Toney, L., Lewin, D.A., Dent, A.L., and Lasky, L.A. (2002). The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 277, 14255-14265. Tartaglia, M., and Gelb, B.D. (2005). Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet 6, 45-68. Tartaglia, M., Mehler, E.L., Goldberg, R., Zampino, G., Brunner, H.G., Kremer, H., van der Burgt, I., Crosby, A.H., Ion, A., Jeffery, S., et al. (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29, 465-468. Tummuru, M.K., Cover, T.L., and Blaser, M.J. (1993). Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 61, 1799-1809. Umehara, S., Higashi, H., Ohnishi, N., Asaka, M., and Hatakeyama, M. (2003). Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene 22, 8337-8342. Vogel, W., Lammers, R., Huang, J., and Ullrich, A. (1993). Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259, 1611-1614. Wang, X., Willen, R., Andersson, C., and Wadstrom, T. (2000). Development of high-grade lymphoma in Helicobacter pylori-infected C57BL/6 mice. APMIS 108, 503-508. Wotherspoon, A.C., Doglioni, C., Diss, T.C., Pan, L., Moschini, A., de Boni, M., and Isaacson, P.G. (1993). Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577. Yang, G.F., Deng, C.S., Xiong, Y.Y., Gong, L.L., Wang, B.C., and Luo, J. (2004). Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection. World J Gastroenterol 10, 491-496. Ye, B.H., Lista, F., Lo Coco, F., Knowles, D.M., Offit, K., Chaganti, R.S., and Dalla-Favera, R. (1993). Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262, 747-750. Zhu, Y., Wang, C., Huang, J., Ge, Z., Dong, Q., Zhong, X., Su, Y., and Zheng, S. (2007). The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis. Cell Microbiol 9, 952-961. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/10647 | - |
| dc.description.abstract | 胃幽門螺旋桿菌（Helicobacter pylori）在分類上屬於革蘭氏陰性菌，病人感染胃幽門螺旋桿菌會造成胃炎、胃潰瘍、十二指腸潰瘍、胃線癌以及胃黏膜相關淋巴組織淋巴瘤。胃幽門螺旋桿菌致病因子CagA是分子量120~145 kD的蛋白質，可經由第四型分泌系統(type IV secretion system)注入宿主細胞內。被送入宿主細胞的CagA會被宿主細胞內的磷酸酶所磷酸化。而磷酸化CagA可與SHP-2結合並活化MAPK訊息傳遞途徑。cagA基因轉殖鼠內，發現除了有胃癌與胃腺癌形成外，有些小鼠會有B淋巴癌生成，但磷酸化耐受性CagA(PR-CagA)的基因轉殖鼠內則觀察不到癌症生成，顯示CagA的磷酸化在B細胞轉型扮演重要角色。為了研究胃幽門螺旋桿菌CagA如何造成B細胞轉型的機制，我們假設胃幽門螺旋桿菌可以直接將CagA送入人類B細胞中，造成B細胞轉型的機率增加。首先我們利用胃幽門螺旋桿菌與BJAB細胞共同培養的系統，發現胃幽門螺旋桿菌能直接將CagA送入B細胞中，且隨著菌量以及時間的增加，可以偵測到磷酸化CagA的增加。為了進一步探討胃幽門螺旋桿菌是否透過CagA影響B細胞的存活，我們觀察CagA對抗細胞凋亡分子Bcl-2與Bcl-xL的影響，結果顯示胃幽門螺旋桿菌可誘導較高的Bcl-2與Bcl-xL表現量，然而在cagA基因剔除菌株中Bcl-2以及Bcl-xL表現量則並不會被誘導起來，因此在胃幽門螺旋桿菌CagA可影響B細胞抗細胞凋亡分子的表現。接著我們探討CagA是否會影響B cell的Bcl-6。我們發現胃幽門螺旋桿菌會抑制Bcl-6蛋白質表現，但是在與cagA基因剔除菌株共同培養後，Bcl-6表現量的抑制則不明顯。利用real-time PCR測量Bcl-2、Bcl-xL以及Bcl-6 mRNA表現，也發現到Bcl-2以及Bcl-xL的 mRNA表現量會被胃幽門螺旋桿菌誘導起來，而Bcl-6的 mRNA表現則會受到抑制，然而在cagA基因剔除菌株與B細胞共同培養的組別並沒有觀察到相同結果。為了觀察SHP-2在胃門幽桿菌調控Bcl-2、Bcl-xL以及Bcl-6的角色，我們利用NSC-87877抑制劑來抑制SHP-2的活性以及利用SHP-2 siRNA抑制SHP-2表現。結果發現Bcl-2, Bcl-xL以及Bcl-6的調控並未受到影響。為了觀察是否CagA單獨存在於B細胞中即會影響B細胞的分子調控，因此我們將野生型CagA以及磷酸化耐受性CagA (PR-CagA)轉染於B細胞中。我們發現在B細胞的Bcl-2以及Bcl-xL表現量在轉染野生型CagA或是磷酸化耐受性CagA的組別皆會被誘導，顯示Bcl-2以及Bcl-xL表現的調控為磷酸化CagA不依賴性。為了探討胃幽門螺旋桿菌是否會增加B細胞的存活，我們給予細胞etoposide測試細胞存活率。我們觀察到B細胞與野生型胃幽門螺旋桿菌共同培養的組別中，細胞的存活率在加入etoposide之後與控制組別差不多，然而在與cagA基因剔除胃幽門螺旋桿菌HM-6共同培養的組別中，細胞死亡情況嚴重。顯示野生型胃幽門螺旋桿菌HM-6可以增加B細胞的存活率。而在轉染CagA到B細胞之後，野生型CagA以及磷酸化耐受性CagA，皆可增加B細胞的存活率。因此抗細胞凋亡分子的表現可能參與胃幽門螺旋桿菌造成胃黏膜相關淋巴組織淋巴瘤的形成機制之一。 | zh_TW |
| dc.description.abstract | Helicobacter pylori is a Gram-negative bacteria. Infection with Helicobacter pylori leads to chronic gastrits, peptic ulcer disease, adenocarcinoma and gastric MALT lymphoma. CagA, a virulent factor of Helicobacter pylori, is an 120~145 kD bacteria protein. CagA could be translocated into the host cell via type IV secretion system. Within host cells, CagA is phosphorylated by protein kinase, and the phospho-CagA could bind to SHP-2, and to activate intracellular MAPK kinase signaling pathway. In cagA transgenic mice, gastric cancer and adenocarcinomas, as well as hematological malignancies were observed to develop in the CagA transgenic mice, but not in transgenic mice expressing phosphorylation-resistant CagA, suggesting that phosphorylation of CagA plays an important role in transformation of B cell. To study the mechanism of Helicobacter pylori CagA in B cell transformation, we proposed that Helicobacter pylori CagA could directly translocated into B cell, and increase the potential of B cell transformation. First, we found that H. pylori translocates CagA directly into B cell and undergoes phosphoralytion in H. pylori and BJAB cell co-culture system in a dose- and time-dependent manner. To further examine whether H. pylori CagA could promote B cell survival via CagA, we investigate the effect of CagA on antiapoptotic molecules Bcl-2 and Bcl-xL. We demonstrated that H. pylori induced higher Bcl-2 and Bcl-XL expression, not in cagA knock-out H. pylori strain in human B cell lines, indicating H. pylori CagA may increase B cell survival. Next we investigated the effects of CagA on expression of Bcl-6. We found that H. pylori could repress Bcl-6 expression, but not in cagA knock-out H. pylori strain. Expression of Bcl-2 and Bcl-xL mRNA is up-regulated while expression of Bcl-6 mRNA is inhibited in wild type but not in cagA knock-out H. pylori strain in real-time PCR analysis. To further investigate the role of SHP-2 in the regulation of Bcl-2 Bcl-xL and Bcl-6 expression, we used SHP-2 inhibitor NSC-87877 to inhibit SHP-2 activity and SHP-2 siRNA to knockdown SHP-2 expression. Our results demonstrated the effects on Bcl-2, Bcl-xL and Bcl-6 is not affected by knocking down SHP-2. To further confirm whether CagA may directly regulate Bcl-2, Bcl-xL and Bcl-6, we transfected WT-CagA or PR-CagA into B cell. The expression of Bcl-2 and Bcl-xL are induced in B cell transfected with either WT-CagA or PR-CagA, indicating that the expression of Bcl-2 and Bcl-xL are phospho-CagA independent. In order to examine whether H. pylori promote B cell survival, we treated B cell with etoposide after co-culture with H. pylori. The results showed that the survival of B cell after co-cultured with cagA knock-out strain was significantly decreased; in contrast, B cell transfected with WT-CagA or PR-CagA showed increased survival rate compare to vector control, suggesting CagA can promote B cell survival. Thus anti-apoptotic molecules induced by CagA might play an important role in transformation of B cell, and in the development of MALT lymphoma. | en |
| dc.description.provenance | Made available in DSpace on 2021-05-20T21:46:36Z (GMT). No. of bitstreams: 1 ntu-99-R97449011-1.pdf: 1519209 bytes, checksum: fe9ee9e3eea3566e57cab48c6f07a69b (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 目錄
誌謝 iv 中文摘要 …..v Abstract vii 研究背景 1 1. 胃幽門螺旋桿菌與致病性之簡介 1 2. CagA 2 3. SHP-2 3 4. Bcl-2、Bcl-xL and Bcl-6 4 材料與方法 7 1. 實驗材料 7 2. 實驗方法 12 實驗結果 16 1. 胃幽門螺旋桿菌可直接將CagA送入人類B細胞株中 16 2. 胃幽門螺旋桿菌可藉由CagA引起B細胞表現較高量的Bcl-2及Bcl-xL …………………………………………………………………………..17 3. 胃幽門螺旋桿菌可藉由CagA抑制B細胞Bcl-6的表現 18 4. SHP-2在胃幽門螺旋桿菌CagA調控Bcl-2, Bcl-xL以及Bcl-6的角色…19 5. CagA轉染於B細胞可引起較高的Bcl-2及Bcl-xL……………………….19 6. 胃幽門螺旋桿菌CagA可以減少B細胞進行細胞凋亡...............................20 結果討論 21 1. 胃幽門螺旋桿菌可以直接將CagA送入B細胞……………………..……21 2. 胃幽門螺旋桿菌透過CagA影響B細胞抗細胞凋亡分子………….…….21 3. SHP-2在胃幽門螺旋桿菌透過CagA影響Bcl-2、 Bcl-xL以及Bcl-6表現扮演之角色…………………………………………………………….22 4. 胃幽門螺旋桿菌CagA影響B細胞存活率….…………………………….23 5. 結論 23 參考文獻 25 圖表說明 35 圖一、胃幽門螺旋桿菌可以將CagA送入B細胞。.....................................35 圖二、胃幽門螺旋桿菌CagA可引起B細胞表現較高量的Bcl-2及Bcl-xL。 …………………………………………………………………………..36 圖三、胃幽門螺旋桿菌CagA引起B細胞的Bcl-2及Bcl-xL mRNA表現增加。 37 圖四、胃幽門螺旋桿菌CagA可抑制B細胞Bcl-6的表現。 38 圖五、胃幽門螺旋桿菌CagA可抑制B細胞Bcl-6 mRNA的表現。 39 圖六、SHP-2在胃幽門螺旋桿菌CagA調控Bcl-2, Bcl-xL以及Bcl-6的角 色。…………………………………………………………………...…40 圖七、CagA轉染於B細胞增高Bcl-2及Bcl-xL的表現。………………...41 圖八、胃幽門螺旋桿菌CagA可減少B細胞對於Etoposide 所引起之細胞 凋亡。…………………………………………………………………...42 | |
| dc.language.iso | zh-TW | |
| dc.title | 胃幽門螺旋桿菌CagA調控Bcl-2、Bcl-xL以及Bcl-6之研究 | zh_TW |
| dc.title | The role of Helicobacter pylori CagA in regulation of Bcl-2, Bcl-xL and Bcl-6 | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 謝世良(Shie-Liang Hsieh),林國儀(Kuo-I Lin) | |
| dc.subject.keyword | 胃幽門螺旋桿菌,CagA,細胞凋亡, | zh_TW |
| dc.subject.keyword | Helicobacter pylori,CagA,Apoptosis, | en |
| dc.relation.page | 42 | |
| dc.rights.note | 同意授權(全球公開) | |
| dc.date.accepted | 2010-08-05 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 免疫學研究所 | zh_TW |
| 顯示於系所單位： | 免疫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf | 1.48 MB | Adobe PDF | 檢視/開啟 |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。